A Phase I//II Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiation Therapy for Locally Advanced Peripheral Non-Small Cell Lung Cancer

被引：0
|
作者：
Li, X. [1 ]
Bo, W. J. [2 ]
Lin, S. [2 ]
Zhang, J. [2 ]
Wen, Q. [2 ]
Yang, B. [3 ]
Ren, P. [3 ]
Pang, H. [2 ]
机构：
[1] SouthWest Med Univ, Affilicated Hosp, Dept Oncol, Luzhou, Peoples R China
[2] SouthWest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1864
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_30_3616
引用
收藏
页码：E692 / E692
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer
    Yamamoto, N
    Nishimura, Y
    Nakagawa, K
    Matsui, K
    Fukuoka, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (03) : 285 - 291
  • [42] A randomised phase II study of two regimens of high dose palliative chemoradiation therapy in the management of locally advanced non-small cell lung cancer (TROG 03.07)
    Michael, Michael
    Burmeister, Bryan
    Burmeister, Elizabeth
    Cox, Sharon
    Horwood, Keith
    Wirth, Andrew
    Sasso, Guiseppe
    Forouzesh, Bahram
    Lehman, Margot
    Ball, David
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S516 - S516
  • [43] A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer
    Chikamori, Kenichi
    Kishino, Daizo
    Takigawa, Nagio
    Hotta, Katsuyuki
    Nogami, Naoyuki
    Kamei, Haruhito
    Kuyama, Shoichi
    Gemba, Kenichi
    Takemoto, Mitsuhiro
    Kanazawa, Susumu
    Ueoka, Hiroshi
    Segawa, Yoshihiko
    Takata, Saburo
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    LUNG CANCER, 2009, 65 (01) : 74 - 79
  • [44] Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
    Bearz, Alessandra
    Minatel, Emilio
    Abu Rumeileh, Imad
    Borsatti, Eugenio
    Talamini, Renato
    Franchin, Giovanni
    Gobitti, Carlo
    Del Conte, Alessandro
    Trovo, Marco
    Baresic, Tanja
    BMC CANCER, 2013, 13
  • [45] Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
    Alessandra Bearz
    Emilio Minatel
    Imad Abu Rumeileh
    Eugenio Borsatti
    Renato Talamini
    Giovanni Franchin
    Carlo Gobitti
    Alessandro Del Conte
    Marco Trovò
    Tanja Baresic
    BMC Cancer, 13
  • [46] Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study
    Hepel, Jaroslaw T.
    Leonard, Kara Lynne
    Safran, Howard
    Ng, Thomas
    Taber, Angela
    Khurshid, Humera
    Birnbaum, Ariel
    Wazer, David E.
    DiPetrillo, Thomas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 1021 - 1027
  • [47] Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study
    Jeter, Melenda D.
    Gomez, Daniel
    Nguyen, Quynh-Nhu
    Komaki, Ritsuko
    Zhang, Xiaodong
    Zhu, Xiaorong
    O'Reilly, Michael
    Fossella, Frank V.
    Xu, Ting
    Wei, Xiong
    Wang, Hui
    Yang, Wenjuan
    Tsao, Anne
    Mohan, Radhe
    Liao, Zhongxing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (03): : 730 - 737
  • [48] Intensity-Modulated Proton Therapy for Elective Nodal Irradiation and Involved-Field Radiation in the Definitive Treatment of Locally Advanced Non-Small-Cell Lung Cancer: A Dosimetric Study
    Kesarwala, Aparna H.
    Ko, Christine J.
    Ning, Holly
    Xanthopoulos, Eric
    Haglund, Karl E.
    O'Meara, William P.
    Simone, Charles B., II
    Rengan, Ramesh
    CLINICAL LUNG CANCER, 2015, 16 (03) : 237 - 244
  • [49] Toxicity report of a phase I/II dose escalation study in inoperable locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy
    Bral, S.
    Versmessen, H.
    Duchateau, M.
    Schallier, D.
    Everaert, H.
    Storme, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 535 - 535
  • [50] Phase I/II study of bortezomib in combination with carboplatin and bevacizumab as first line therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Piperdi, Bilal
    Bradley, Kendra J.
    Bathini, Venu
    Zekos, Colleens M.
    Hanrahan-Boshes, Meredith
    Walsh, William V.
    CANCER RESEARCH, 2010, 70
12345